11/12
08:30 am
mbio
Mustang Bio Receives Positive Listing Determination from Nasdaq
Low
Report
Mustang Bio Receives Positive Listing Determination from Nasdaq
11/7
08:30 am
mbio
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
Low
Report
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
10/27
09:15 am
mbio
Mustang Bio Secures $4M through Strategic Warrant Agreement [Yahoo! Finance]
Medium
Report
Mustang Bio Secures $4M through Strategic Warrant Agreement [Yahoo! Finance]
10/24
02:10 pm
mbio
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
Low
Report
Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds